Aging Clinical and Experimental Research

, Volume 10, Issue 6, pp 449–454 | Cite as

Serum leptin and longevity

  • H. A. Koistinen
  • V. A. Koivisto
  • S-L. Karonen
  • T. Rönnemaa
  • R. S. Tilvis
Original Article


There are changes in the ability to regulate energy balance and caloric intake with aging. Consequently, we investigated whether human aging modifies the levels of serum leptin, a novel hormone implicated in the regulation of energy balance. We studied 268 Caucasian men and women aged 22–85 years, and divided them into groups with mean ages of 30, 40, 50, 65, 75, 80 and 85 years. Fasting serum leptin concentrations were determined by radioimmunoassay. Subjects aged 65 or older were followed for five years after the blood sampling. There were no statistically significant differences in fasting serum leptin concentrations across different age groups in females (p=0.090). Fasting serum leptin concentrations were also similar in different age groups in males, except that males in the 30-year age group had lower serum leptin levels than males in the 75-year age group (p=0.042). Leptin levels were 2–3 fold higher in females than in males in each age group (p<0.005 except p=0.063 in the 75-year age group). Elderly women, who lived longer, had 47% higher (p<0.05) serum leptin concentrations, and 17% higher (p<0.001) BMI than the women who died within five years of blood sampling. Leptin levels were not statistically different in these women after adjusting for BMI. Thus, aging has no apparent effect on serum leptin levels in women or men, and the gender difference in leptin is present also in the older age groups. Higher leptin concentrations in the females who live longer may reflect a better nutritional status, and a greater adipose tissue mass rather than a primary factor for survival.

Key words

Aging body mass index insulin leptin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M.: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432, 1994.PubMedCrossRefGoogle Scholar
  2. 2.
    Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P.: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546–549, 1995.PubMedCrossRefGoogle Scholar
  3. 3.
    Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.I., Burley S.K., Friedman J.M.: Weight reducing effects of the plasma protein encoded by the obese gene. Science 269: 543–546, 1995.PubMedCrossRefGoogle Scholar
  4. 4.
    Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F.: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540–543, 1995.PubMedCrossRefGoogle Scholar
  5. 5.
    Frederich R.C., Hamann A., Anderson S., Löllmann B., Lowell B.B., Flier J.S.: Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine 1: 1311–1314, 1995.PubMedCrossRefGoogle Scholar
  6. 6.
    Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.R., Caro J.F.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292–295, 1996.PubMedCrossRefGoogle Scholar
  7. 7.
    Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A., Friedman J.M.: Leptin levels in human and rodent: Measurement of plasma leptin and ob mRNA in obese and weight reduced subjects. Nature Medicine 1: 1155–1161, 1995.PubMedCrossRefGoogle Scholar
  8. 8.
    Kolaczynski J.W., Considine R.V., Ohannesian J., Marco C., Opentanova I., Nyce M.R., Myint M., Caro J.F.: Responses of leptin to short-term fasting and refeeding in humans. A link with ketogenesis but not ketones themselves. Diabetes 45: 1511–1515, 1996.PubMedCrossRefGoogle Scholar
  9. 9.
    Roberts S.B., Fuss P., Heyman M.B., Evans W.J., Tsay R., Rasmussen H., Fiatarone M., Cortiella J., Dallal G.E., Young V.R.: Control of food intake in older men. JAMA 272: 1601–1606, 1994.PubMedCrossRefGoogle Scholar
  10. 10.
    McGandy R.B., Barrows C.H., Spanias A., Meredith A., Stone J.L., Norris A.H.: Nutrient intake and energy expenditure in men of different ages. J. Gerontol. 21: 581–584, 1996.CrossRefGoogle Scholar
  11. 11.
    Munro H.N., Suter P.M., Russel R.M.: Nutritional requirements of the elderly. Annu. Rev. Nutr. 7: 23–49, 1987.PubMedCrossRefGoogle Scholar
  12. 12.
    Poehlman E.T.: Regulation of energy expenditure in aging humans. J. Am. Ger. Soc. 41: 552–559, 1996.Google Scholar
  13. 13.
    Strandberg T.E., Valvanne J., Erkinjuntti T., Sorva A., Tilvis R.S.: Serum lipids, health, and one-year mortality in randomized age cohorts of 75, 80, and 85 years: the Helsinki Ageing Study. Nutr. Metab. Cardiovasc. Dis. 2: 101–105, 1992.Google Scholar
  14. 14.
    Hakala S-M., Tilvis R.S., Strandberg T.E.: Blood pressure and mortality in a general aged population: a five-year follow-up of the Helsinki Aging Study. Eur. Heart J. 18: 1019–1023, 1997.PubMedCrossRefGoogle Scholar
  15. 15.
    Ma Z., Gingerich R.L., Santiago J.V., Klein S., Smith C.H., Landt M.: Radioimmunoassay of leptin in human plasma. Clin. Chem. 42: 942–946, 1996.PubMedGoogle Scholar
  16. 16.
    Finley P.R., Schifman R.B., Williams R.J., Lichti D.A.: Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymatic measurement. Clin. Chem. 26: 931–933, 1978.Google Scholar
  17. 17.
    Siedel J., Hägele E.O., Ziegenhorn J., Wahlefeldt A.W.: Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem. 29: 1075–1080, 1983.PubMedGoogle Scholar
  18. 18.
    Bergmeier H.U.: Metoden der enzymatischen Analyse. 3. Auflage, Bd II, Verlag Chemie Weinheim, 1974, p. 1878.Google Scholar
  19. 19.
    Desbuquouis B., Aurbach G.D.: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocr. 33: 732–738, 1971.CrossRefGoogle Scholar
  20. 20.
    Dixon W.J. (Ed.): BMDP. Statistical Software. University of California Press, London, 1988.Google Scholar
  21. 21.
    Roberts S.B., Nicholson M., Staten M., Dallal G.E., Sawaya A.L., Heyman M.B., Fuss P., Greenberg A.S.: Relationship between circulating leptin and energy expenditure in adult men and women aged 18 years to 81 years. Obes. Res. 5: 459–463, 1997.PubMedCrossRefGoogle Scholar
  22. 22.
    Moller N., O’Brien P., Nair K.S.: Disruption of the relationship between fat content and leptin levels with aging in humans. J. Clin. Endocrinol. Metab. 83: 931–934, 1998.PubMedGoogle Scholar
  23. 23.
    Ostlund R.E., Yang J.W., Klein S., Gingerich R.: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J. Clin. Endocrinol. Metab. 81: 3909–3913, 1996.PubMedGoogle Scholar
  24. 24.
    Rönnemaa T., Karonen S-L., Rissanen A., Koskenvuo M., Koivisto V.A.: Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann. Intern. Med. 126: 26–31, 1997.PubMedCrossRefGoogle Scholar
  25. 25.
    Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., Leibel R.: Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 81: 3424–3427, 1996.PubMedGoogle Scholar
  26. 26.
    Wabitsch M., Blum W.F., Muche R., Braun M., Hube F., Rascher W., Heinze E., Teller W., Hauner H.: Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J. Clin. Invest. 100: 808–813, 1997.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Corti M-C., Guralnik J.M., Salive M.E., Harris T., Ferrucci L., Glynn R.J., Havlik R.J.: Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann. Intern. Med. 126: 753–760, 1997.PubMedCrossRefGoogle Scholar
  28. 28.
    de Courten M., Zimmet P., Hodge A., Collins V., Nicolson M., Staten M., Dowse G., Alberti K.G.M.M.: Hyperleptinaemia: the missing link in the metabolic syndrome. Diabetic Med. 14: 200–208, 1997.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Internal Publishing Switzerland 1998

Authors and Affiliations

  • H. A. Koistinen
    • 1
  • V. A. Koivisto
    • 1
  • S-L. Karonen
    • 2
  • T. Rönnemaa
    • 3
  • R. S. Tilvis
    • 1
  1. 1.Department of Medicine, Ward 112, Room 29Helsinki University Central HospitalHelsinkiFinland
  2. 2.Department of Clinical ChemistryHelsinki University Central HospitalHelsinkiFinland
  3. 3.Department of MedicineTurku University Central HospitalTurkuFinland

Personalised recommendations